← Back to Search

Behavioral Intervention

VR-JIT + MCT for Self-Discipline and Relapse

N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and posttest (approximately 8 weeks after baseline)
Awards & highlights

Study Summary

This trial tests a self-control training and virtual job interview program to help formerly incarcerated people. It also looks at how well the program was implemented.

Who is the study for?
This trial is for adults over 18 who are part of the A Brighter Way Program and can read at a third-grade level or higher. It's not suitable for those with uncorrected hearing or vision problems that would interfere with training.Check my eligibility
What is being tested?
The study tests if teaching self-control skills (MCT) along with practicing job interviews in virtual reality (VR-JIT) helps formerly incarcerated people do better in real-life interviews. Participants are randomly assigned to different groups to compare results.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects aren't expected. However, participants may experience discomfort or stress related to interview practice or confronting personal challenges during self-control training.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and posttest (approximately 8 weeks after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and posttest (approximately 8 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Symptomology measured by ADHD Self-Report Scale (ASRS)
Change in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Symptomology measured by the Structured Clinical Interview (SCID-RV) for The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Change in Employment Outcome
+3 more
Secondary outcome measures
Change in Recidivism

Trial Design

2Treatment groups
Experimental Treatment
Group I: Virtual Reality Job Interview Training (VR-JIT)Experimental Treatment1 Intervention
This group will receive just the VR-JIT intervention. We are anticipating 6-8 weeks, with 1-3 sessions per week for this intervention.
Group II: Metacognitive Self-Control Training (MCT) + Virtual Reality Job Interview Training (VR-JIT)Experimental Treatment2 Interventions
This group will receive the MCT intervention plus the VR-JIT intervention. We are anticipating 6-8 weeks, with 1-3 sessions per week for each intervention.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,916 Total Patients Enrolled

Media Library

Metacognitive Self-Control Training (MCT) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05966831 — N/A
Self-Discipline Research Study Groups: Metacognitive Self-Control Training (MCT) + Virtual Reality Job Interview Training (VR-JIT), Virtual Reality Job Interview Training (VR-JIT)
Self-Discipline Clinical Trial 2023: Metacognitive Self-Control Training (MCT) Highlights & Side Effects. Trial Name: NCT05966831 — N/A
Metacognitive Self-Control Training (MCT) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05966831 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment presently seeking participants?

"Clinicaltrials.gov reveals that enrollment for this trial is closed. Posting on August 1st, 2023 and last updated July 25th 2023, no new patients are being accepted at the present time; however, 12 other trials are currently seeking participants."

Answered by AI
~14 spots leftby Oct 2024